Cambridge Investment Research Advisors
EDEN icon

Cambridge Investment Research Advisors’s iShares MSCI Denmark ETF EDEN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EDEN Stock Details EDEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
16,975
-23,061
-58% -$2.54M ﹤0.01% 1620
2026
Q1 		$4.19M Buy
+40,036
New +$4.5M 0.01% 1069
2024
Q1 		– Sell
-4,297
Closed -$482K – 3331
2023
Q4 		$482K Buy
+4,297
New +$443K ﹤0.01% 2202

Other funds holding EDEN

MAM
Marotta Asset Management Charlottesville, Virginia $601M AUM 21.35% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Cambridge Investment Research Advisors's EDEN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its iShares MSCI Denmark ETF (EDEN) stake by 58% in Q2 2026, selling an estimated $2.54M and leaving 16,975 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Cambridge Investment Research Advisors first reported a position in EDEN in Q4 2023 and has held it in 3 quarters since. The position peaked at $4.19M in Q1 2026. 4 funds tracked by Wall St. Rank hold EDEN as of Q2 2026.

  • Cambridge Investment Research Advisors held 16,975 shares of iShares MSCI Denmark ETF worth $1.87M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 23,061 iShares MSCI Denmark ETF shares in Q2 2026, an estimated $2.54M.
  • iShares MSCI Denmark ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1620 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares MSCI Denmark ETF in Q4 2023 and has held it in 3 quarters since.
  • Cambridge Investment Research Advisors's iShares MSCI Denmark ETF position peaked at $4.19M in Q1 2026.
  • 4 funds tracked by Wall St. Rank held iShares MSCI Denmark ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.